The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Construction contracts for major national general contractor
Represented numerous general contractors on construction of several facilities at a university, including: (a) Field Renovation and Expansion: We more
Defense Verdict in Disability Discrimination Trial
Represented UnumProvident Corporation, a leading benefits provider worldwide, in a lawsuit in which the plaintiff claimed that he was discriminated more
Consolidation of PetroLiance LLC
The firm served as lead counsel for PetroLiance LLC, an oil company, in four-way consolidation that created the nation’s largest distributor of more
Class action for an aerospace manufacturing company
Represented an aerospace manufacturing company in a race discrimination class action lawsuit in which we defeated class certification and achieved more